River Street Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-12,161
Closed -$971K 145
2024
Q4
$971K Buy
12,161
+267
+2% +$23.1K 0.5% 57
2024
Q3
$1.07M Buy
11,894
+173
+1% +$14.6K 0.58% 52
2024
Q2
$923K Buy
11,721
+742
+7% +$60.8K 0.57% 52
2024
Q1
$957K Buy
10,979
+2,304
+27% +$197K 0.65% 47
2023
Q4
$715K Sell
8,675
-1,986
-19% -$151K 0.57% 52
2023
Q3
$835K Buy
10,661
+467
+5% +$39.1K 0.79% 41
2023
Q2
$898K Sell
10,194
-323
-3% -$27.8K 0.86% 37
2023
Q1
$848K Buy
10,517
+641
+6% +$52.2K 0.83% 41
2022
Q4
$768K Buy
+9,876
New +$800K 0.82% 41

Other funds holding MDT

River Street Advisors's MDT Position: Q1 2025 in Review

River Street Advisors sold out of Medtronic (MDT) in Q1 2025, closing a stake of 12,161 shares — an estimated $971K sold.

River Street Advisors first reported a position in MDT in Q4 2022 and held it in 9 quarters. The position peaked at $1.07M in Q3 2024. 2,170 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

  • River Street Advisors reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
  • River Street Advisors sold 12,161 Medtronic shares in Q1 2025, an estimated $971K.
  • River Street Advisors first reported a position in Medtronic in Q4 2022 and held it in 9 quarters.
  • River Street Advisors's Medtronic position peaked at $1.07M in Q3 2024.
  • 2,170 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on River Street Advisors's 13F filing for Q1 2025, filed 21 Apr 2025.